Delivery Order SPE2DB22D3011-SPE2DB25FQ2JP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, a common broad-spectrum antibiotic used extensively in military and federal healthcare systems. This firm fixed price delivery order, valued at $9,528.22, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 through...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,527.09 by the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, an intravenous antibiotic commonly used in military and federal healthcare settings. The contract is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This award was made through open competition...
- The Defense Logistics Agency awarded a delivery order valued at $1,696.38 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This firm fixed-price delivery order, valued at $4,324.77, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,548.17 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic used in military and federal healthcare settings. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The award was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and the product will be delivered to Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ceftriaxone 1 GM-D5W bags with a ceiling value of $3,436.68. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken facility. Ceftriaxone...
- The Defense Logistics Agency awarded a $1,498.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with completion scheduled for June 2, 2025. This competitively awarded, firm fixed-price contract requires performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $9,224.08 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare systems. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance will be completed by August 13, 2025, with the product supplied from AmerisourceBergen's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,328.85 to supply Ceftriaxone 1 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare systems. This non-competitive delivery order was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, under a firm fixed price arrangement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a common antibiotic used across military and federal healthcare systems. This firm fixed-price delivery order, valued at $6,774.10, was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2JPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,417.62 and is scheduled for completion by August 22, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements through open competition, ranging from routine pharmaceutical orders to specialized medical commodities supporting military operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/21/25 |